Skip to main content
. 2016 Mar 26;7(18):25826–25835. doi: 10.18632/oncotarget.8404

Figure 2. Differences in FGFR3 gene and TERT promoter mutations between Han Chinese and Western patients with urothelial cell carcinoma.

Figure 2

RPC, renal pelvic carcinoma; UC, ureter carcinoma; UBC, urothelial bladder carcinoma. -: No data available from Western UC patients.